Sharon Ham

Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial

A. Doney, C. Hawkey, A. Avery, 2022, The Lancet.